摘要
The standard rabies vaccines recommended by WHO include Essen regimen, the Thai Red Cross two-site ID regimen and the eight-site ID regimen, and so on. The present schedules of rabies vaccine are all laborious and time consuming. We developed a new rabies vaccine with liposome as adjuvant（LipoRabV） and found that liposome could facilitate the inactivated rabies vaccine（RabV） to induce the more vigorous production of rabies virus neutralizing antibody（RVNA） in BALB/c mice and beagles. We established preliminary pre- and post-exposure prophylaxis schedules for LipoRabV. LipoRabV（0/14） could elicit similar RVNA level as RabV（0/7/28） by pre-exposure prophylaxis schedules in mice and beagles. LipoRabV（0/3/14） could elicit higher RVNA level vs. RabV（0/3/7/14/28） in BALB/c. The data indicate that the three-shot liposome-enhanced rabies vaccine could achieve a higher protection rate（survival rate 56.2%） by post-exposure prophylaxis compared with that of the RabV group（survival rate 40.6%） in mice. The data also indicate that the three-inoculation liposome-enhanced rabies vaccine could achieve a survival rate of 80.0% vs. RabV（70.0%） by post-exposure prophylaxis in beagles. The results show that the immunization schedule for LipoRabV could be preliminarily determined at 0 and 14 d for pre-exposure prophylaxis and at 0, 3 and 14 d for post-exposure prophylaxis.
The standard rabies vaccines recommended by WHO include Essen regimen, the Thai Red Cross two-site ID regimen and the eight-site ID regimen, and so on. The present schedules of rabies vaccine are all laborious and time consuming. We developed a new rabies vaccine with liposome as adjuvant（LipoRabV） and found that liposome could facilitate the inactivated rabies vaccine（RabV） to induce the more vigorous production of rabies virus neutralizing antibody（RVNA） in BALB/c mice and beagles. We established preliminary pre- and post-exposure prophylaxis schedules for LipoRabV. LipoRabV（0/14） could elicit similar RVNA level as RabV（0/7/28） by pre-exposure prophylaxis schedules in mice and beagles. LipoRabV（0/3/14） could elicit higher RVNA level vs. RabV（0/3/7/14/28） in BALB/c. The data indicate that the three-shot liposome-enhanced rabies vaccine could achieve a higher protection rate（survival rate 56.2%） by post-exposure prophylaxis compared with that of the RabV group（survival rate 40.6%） in mice. The data also indicate that the three-inoculation liposome-enhanced rabies vaccine could achieve a survival rate of 80.0% vs. RabV（70.0%） by post-exposure prophylaxis in beagles. The results show that the immunization schedule for LipoRabV could be preliminarily determined at 0 and 14 d for pre-exposure prophylaxis and at 0, 3 and 14 d for post-exposure prophylaxis.
基金
Supported by the National High-Tech Research and Development Programs of China(No.2006AA02A221)
